Target intelligence / Profile preview

Novel transcript, antisense to RRP1B

Molecular classification
Other (Noncoding RNA, antisense RNA)
01

Overview

Novel transcript, antisense to RRP1B" (ENSG00000303490, LOC124905030) is an annotated noncoding RNA predicted to be transcribed in the antisense orientation relative to the protein-coding gene Ribosomal RNA Processing 1B (RRP1B). There is no experimental evidence defining its expression, function, protein product, biological pathways, or involvement in human disease. It is not recognized as a therapeutic target, receptor, enzyme, or biomarker in major gene, protein, or drug databases. Most characterized functions and any therapeutic interest pertain to RRP1B itself, not its antisense transcripts[1][3][4]. If your intent is to investigate RRP1B as a therapeutic target or molecular entity, refer instead to "Ribosomal RNA processing 1B" for structured information[1][3][4]. This antisense transcript remains a poorly characterized genomic annotation with unknown biological or clinical significance.

Other names
novel transcript, antisense to RRP1BLOC124905030ENSG00000303490
02

Biological functions

Other (No defined functions; by annotation, presumed antisense RNA, possibly involved in transcriptional or post-transcriptional regulation if functional)
03

Disease associations

Other (No established disease role; no evidence of direct involvement in disease in GeneCards, UniProt, or peer-reviewed articles[1][3])

Beyond the preview

Go deeper on Novel transcript, antisense to RRP1B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RRP1B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call